title: Galectin Binding to Neo-Glycoproteins: LacDiNAc Conjugated BSA as Ligand for Human Galectin-3.
abstract: Carbohydrate-lectin interactions are relatively weak. As they play an important role in biological recognition processes, multivalent glycan ligands are designed to enhance binding affinity and inhibitory potency. We here report on novel neo-glycoproteins based on bovine serum albumin as scaffold for multivalent presentation of ligands for galectins. We prepared two kinds of tetrasaccharides (N-acetyllactosamine and N,N-diacetyllactosamine terminated) by multi-step chemo-enzymatic synthesis utilizing recombinant glycosyltransferases. Subsequent conjugation of these glycans to lysine groups of bovine serum albumin via squaric acid diethyl ester yielded a set of 22 different neo-glycoproteins with tuned ligand density. The neo-glycoproteins were analyzed by biochemical and chromatographic methods proving various modification degrees. The neo-glycoproteins were used for binding and inhibition studies with human galectin-3 showing high affinity. Binding strength and inhibition potency are closely related to modification density and show binding enhancement by multivalent ligand presentation. At galectin-3 concentrations comparable to serum levels of cancer patients, we detect the highest avidities. Selectivity of N,N-diacetyllactosamine terminated structures towards galectin-3 in comparison to galectin-1 is demonstrated. Moreover, we also see strong inhibitory potency of our scaffolds towards galectin-3 binding. These novel neo-glycoproteins may therefore serve as selective and strong galectin-3 ligands in cancer related biomedical research.
authors.affiliation: Laboratory for Biomaterials, Institute for Biotechnology and Helmholtz-Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstr. 20, 52074 Aachen, Germany. s.boecker@biotec.rwth-aachen.de.
authors.forename: Sophia
authors.initials: S
authors.lastname: Böcker
authors.affiliation: Laboratory for Biomaterials, Institute for Biotechnology and Helmholtz-Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstr. 20, 52074 Aachen, Germany. d.laaf@biotec.rwth-aachen.de.
authors.forename: Dominic
authors.initials: D
authors.lastname: Laaf
authors.affiliation: Laboratory for Biomaterials, Institute for Biotechnology and Helmholtz-Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstr. 20, 52074 Aachen, Germany. l.elling@biotec.rwth-aachen.de.
authors.forename: Lothar
authors.initials: L
authors.lastname: Elling
mesh_terms: D000818:Animals; D002236:Carbohydrate Conformation; D002417:Cattle; D037483:Galectin 1 / Q000378:metabolism; D037502:Galectin 3 / Q000378:metabolism*; D006023:Glycoproteins / Q000138:chemical synthesis / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D007785:Lactose / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism; D008024:Ligands; D008958:Models, Molecular; D011485:Protein Binding / Q000187:drug effects; D012710:Serum Albumin, Bovine / Q000378:metabolism*
chemical_list: D037483:Galectin 1; D037502:Galectin 3; D006023:Glycoproteins; D008024:Ligands; C093701:N-acetylgalactosaminyl-1-4-N-acetylglucosamine; D012710:Serum Albumin, Bovine; D007785:Lactose
keywords: LacDiNAc; chemo-enzymatic synthesis; galectin-3; multivalency; neo-glycoproteins